Tags

Type your tag names separated by a space and hit enter

Needle-free skin patch delivery of a vaccine for a potentially pandemic influenza virus provides protection against lethal challenge in mice.
Clin Vaccine Immunol. 2007 Jul; 14(7):926-8.CV

Abstract

In the event of another influenza virus pandemic, strategies for effective mass vaccination will urgently be needed. We used a novel transdermal patch delivery technology, known as the PassPort system, to vaccinate mice with recombinant H5 hemagglutinin with or without immunomodulators. This needle-free form of vaccine delivery induced robust serum antibody responses that were augmented by different immunomodulators that stimulated the innate immune system and protected mice against lethal challenge with a highly pathogenic avian H5N1 influenza virus.

Authors+Show Affiliations

Influenza Division, Mail-Stop G-16, CCID, Centers for Disease Control and Prevention, 1600 Clifton Rd., Atlanta, GA 30333, USA.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

17494637

Citation

Garg, Sanjay, et al. "Needle-free Skin Patch Delivery of a Vaccine for a Potentially Pandemic Influenza Virus Provides Protection Against Lethal Challenge in Mice." Clinical and Vaccine Immunology : CVI, vol. 14, no. 7, 2007, pp. 926-8.
Garg S, Hoelscher M, Belser JA, et al. Needle-free skin patch delivery of a vaccine for a potentially pandemic influenza virus provides protection against lethal challenge in mice. Clin Vaccine Immunol. 2007;14(7):926-8.
Garg, S., Hoelscher, M., Belser, J. A., Wang, C., Jayashankar, L., Guo, Z., Durland, R. H., Katz, J. M., & Sambhara, S. (2007). Needle-free skin patch delivery of a vaccine for a potentially pandemic influenza virus provides protection against lethal challenge in mice. Clinical and Vaccine Immunology : CVI, 14(7), 926-8.
Garg S, et al. Needle-free Skin Patch Delivery of a Vaccine for a Potentially Pandemic Influenza Virus Provides Protection Against Lethal Challenge in Mice. Clin Vaccine Immunol. 2007;14(7):926-8. PubMed PMID: 17494637.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Needle-free skin patch delivery of a vaccine for a potentially pandemic influenza virus provides protection against lethal challenge in mice. AU - Garg,Sanjay, AU - Hoelscher,Mary, AU - Belser,Jessica A, AU - Wang,Chong, AU - Jayashankar,Lakshmi, AU - Guo,Zhu, AU - Durland,Ross H, AU - Katz,Jacqueline M, AU - Sambhara,Suryaprakash, Y1 - 2007/05/09/ PY - 2007/5/15/pubmed PY - 2007/11/6/medline PY - 2007/5/15/entrez SP - 926 EP - 8 JF - Clinical and vaccine immunology : CVI JO - Clin Vaccine Immunol VL - 14 IS - 7 N2 - In the event of another influenza virus pandemic, strategies for effective mass vaccination will urgently be needed. We used a novel transdermal patch delivery technology, known as the PassPort system, to vaccinate mice with recombinant H5 hemagglutinin with or without immunomodulators. This needle-free form of vaccine delivery induced robust serum antibody responses that were augmented by different immunomodulators that stimulated the innate immune system and protected mice against lethal challenge with a highly pathogenic avian H5N1 influenza virus. SN - 1556-6811 UR - https://www.unboundmedicine.com/medline/citation/17494637/Needle_free_skin_patch_delivery_of_a_vaccine_for_a_potentially_pandemic_influenza_virus_provides_protection_against_lethal_challenge_in_mice_ L2 - http://cvi.asm.org/cgi/pmidlookup?view=long&pmid=17494637 DB - PRIME DP - Unbound Medicine ER -